fillwise.fillwise.

Look up one drug

Ontario coverage, price, criteria word for word, Health Canada status and shortages for one product

Medication plan: estimated costs for a whole medication list

Clindamycin phosphate & benzoyl peroxide

All products: general benefit

Taro-Clindamycin/Benzoyl Peroxide Gel · DIN 02440180 · 1% & 5% · Gel

General benefitMarketed · checked November 18, 2026
StatusGeneral benefit
Write on scriptno code needed
Patient paysNot calculated: no patient details entered. Add age and coverage above to see what this patient would pay.
Private plan not entered. Private-plan coverage, and how it coordinates with public programs, is not determined here; the Ontario public-program lines on this page remain conditional on the entered details and the program rules.
1 brand, same coverage
Taro-Clindamycin/Benzoyl Peroxide Gel · DIN 02440180 Manufacturer: Taro Pharmaceuticals Inc.; listing date 2016-02-25 Health Canada: Marketed since 2015-08-05 · brand TARO-CLINDAMYCIN/BENZOYL PEROXIDE GEL · ATC D10AF51 CLINDAMYCIN, COMBINATIONS · form Gel · route Topical · ingredients CLINDAMYCIN (CLINDAMYCIN PHOSPHATE) 1 %/W/W, BENZOYL PEROXIDE 5 %/W/W · company Taro pharmaceuticals inc · schedule Prescription
Re-check Health Canada status and shortages (live) · Health Canada product record

Taro-Clindamycin/Benzoyl Peroxide Gel: Formulary list price $0.69 per unit (the source does not state the unit; exact figure $0.6857). What the ministry pays, not the patient.

Ministry pays: $0.6857 per source unit.

Source explanation: The formulary price is what ODB pays; the cash price at the counter is set by the pharmacy.

Formulary data: Ontario extract of September 22, 2026 · Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · Health Canada DPD page · Verify on the e-Formulary ↗ (DIN 02440180)

Source record
DIN 02440180: Taro-Clindamycin/Benzoyl Peroxide Gel Raw flags: sec3=Y Item: 840404028; group id 811; item number 1989; lccId None; manufacturer id TAR Source form: Gel; strength: 1% & 5% Recorded listing: General benefit Source prices (unrounded): $0.6857; ministry $0.6857 Source: ODB odb-formulary-ed43-extract-2026-09-22.xml extract_date=September 22, 2026 DIN=02440180 Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=92456
Interchangeable products
Clindoxyl · DIN 02243158 · $0.6857
Shortage status: not checked (no credentials)

Other products in the same Health Canada class (D10AF): coverage varies; not interchangeable

  • Adapalene + benzoyl peroxide + clindamycin (Cabtreo): limited Use 724
  • Clindamycin (Dalacin T 1%): not a benefit
Other drugs in the same formulary class (84:04:04 Antibiotics) and how they are covered

Matched class: 84:04:04 Antibiotics

Drug-class inventory only. Lists recorded Ontario formulary products, not every Canadian medication; does not recommend treatment. Covered without a code on the Ontario formulary: FUSIDIC ACID, MUPIROCIN CALCIUM, SODIUM FUSIDATE Some products covered without a code (check the product listing): MUPIROCIN 84:04:04 Antibiotics

CLINDAMYCIN PHOSPHATE & ADAPALENE & BENZOYL PEROXIDE

· 1 products · Limited Use, codes 724 · strengths: 1.2% w/w & 0.15% w/w & 3.1% w/w · Top Gel Pump

CLINDAMYCIN

· 2 products · Off-Formulary Interchangeable, not an ODB benefit · strengths: 1% · Top Sol

FUSIDIC ACID

· 2 products · General benefit · strengths: 2% · Cr

MUPIROCIN

· 2 products · Listed, not a benefit (1), General benefit (1) · strengths: 2% · Oint

MUPIROCIN CALCIUM

· 1 products · General benefit · strengths: 2% w/w · Cr

SODIUM FUSIDATE

· 2 products · General benefit · strengths: 2% · Oint Source: formulary-ed43-front-matter.txt Part V; ODB odb-formulary-ed43-extract-2026-09-22.xml extract_date=2026-09-22; class 84:04:04
Full class listing Related classes: 84:04:08 Fungicides, 84:04:12 Parasiticides, 84:04:16 Other Anti-Infectives Same formulary class, not same indication: class membership alone does not establish equivalent uses.
What the Health Canada label says it is for
INDICATIONS AND CLINICAL USE BENZACLIN (clindamycin, as phosphate, 1% and benzoyl peroxide 5%) is indicated for:  The topical treatment of moderate acne vulgaris characterized by comedones, inflammatory papules/pustules, with or without an occasional cyst or nodule (Grade II to III 1). BENZACLIN contains an antibacterial ingredient, clindamycin. To reduce the risk of development of drug-resistant bacteria and maintain the effectiveness of clindamycin, BENZACLIN should only be used for the authorized indication and clinical use. BENZACLIN is not indicated for the treatment of cystic acne (Grade IV 1). https://pdf.hres.ca/dpd_pm/00060577.PDF PM date: March 29, 2021 Source product: BENZACLIN; DIN 02248472; fetched 2026-09-10 Product monograph posted by Health Canada; excerpt for lookup only.